These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33536495)

  • 21. Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis.
    Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Bassett IV
    BMC Pulm Med; 2016 Nov; 16(1):147. PubMed ID: 27842535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.
    Dheda K; Davids V; Lenders L; Roberts T; Meldau R; Ling D; Brunet L; van Zyl Smit R; Peter J; Green C; Badri M; Sechi L; Sharma S; Hoelscher M; Dawson R; Whitelaw A; Blackburn J; Pai M; Zumla A
    PLoS One; 2010 Mar; 5(3):e9848. PubMed ID: 20352098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
    Yakhelef N; Audibert M; Ferlazzo G; Sitienei J; Wanjala S; Varaine F; Bonnet M; Huerga H
    PLoS One; 2020; 15(1):e0227138. PubMed ID: 31999746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
    Gupta-Wright A; Peters JA; Flach C; Lawn SD
    BMC Med; 2016 Mar; 14():53. PubMed ID: 27007773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients.
    Mutetwa R; Boehme C; Dimairo M; Bandason T; Munyati SS; Mangwanya D; Mungofa S; Butterworth AE; Mason PR; Corbett EL
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1253-9. PubMed ID: 19793430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
    Schramm B; Nganaboy RC; Uwiragiye P; Mukeba D; Abdoubara A; Abdou I; Nshimiymana JC; Sounna S; Hiffler L; Flevaud L; Huerga H
    PLoS One; 2021; 16(5):e0250933. PubMed ID: 33951082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Structural Study of Terminal Ends of Lipoarabinomannan from Mice Infected Lung Tissues and Urine of a Tuberculosis Positive Patient.
    De P; Shi L; Boot C; Ordway D; McNeil M; Chatterjee D
    ACS Infect Dis; 2020 Feb; 6(2):291-301. PubMed ID: 31762254
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.
    Nakiyingi L; Moodley VM; Manabe YC; Nicol MP; Holshouser M; Armstrong DT; Zemanay W; Sikhondze W; Mbabazi O; Nonyane BA; Shah M; Joloba ML; Alland D; Ellner JJ; Dorman SE
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):270-9. PubMed ID: 24675585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis.
    Gounder CR; Kufa T; Wada NI; Mngomezulu V; Charalambous S; Hanifa Y; Fielding K; Grant A; Dorman S; Chaisson RE; Churchyard GJ
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):219-23. PubMed ID: 21765364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.
    Lawn SD; Edwards DJ; Kranzer K; Vogt M; Bekker LG; Wood R
    AIDS; 2009 Sep; 23(14):1875-80. PubMed ID: 20108382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis.
    Boehme C; Molokova E; Minja F; Geis S; Loscher T; Maboko L; Koulchin V; Hoelscher M
    Trans R Soc Trop Med Hyg; 2005 Dec; 99(12):893-900. PubMed ID: 16139316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
    Gina P; Randall PJ; Muchinga TE; Pooran A; Meldau R; Peter JG; Dheda K
    BMC Infect Dis; 2017 May; 17(1):339. PubMed ID: 28499418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
    Drain PK; Gounder L; Grobler A; Sahid F; Bassett IV; Moosa MY
    BMJ Open; 2015 Apr; 5(4):e006833. PubMed ID: 25877271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study.
    Kebede W; Abebe G; Gudina EK; Van Rie A
    Sci Rep; 2021 Dec; 11(1):24428. PubMed ID: 34952913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?
    Sabur NF; Esmail A; Brar MS; Dheda K
    BMC Infect Dis; 2017 Dec; 17(1):803. PubMed ID: 29282005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
    Shah M; Ssengooba W; Armstrong D; Nakiyingi L; Holshouser M; Ellner JJ; Joloba M; Manabe YC; Dorman SE
    AIDS; 2014 Jun; 28(9):1307-14. PubMed ID: 24637544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
    Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients.
    Connelly JT; Andama A; Grant BD; Ball A; Mwebe S; Asege L; Nakaye M; Lopez BB; Hsieh HV; Katumba D; Mukwatamundu J; Nalubega M; Hunt VM; Burkot S; Ramachandraiah H; Choudhary A; Ignatowicz L; Weigl BH; Bachman C; Mulondo J; Semitala F; Worodria W; Pinter A; Hamasur B; Bell D; Cattamanchi A; Somoskovi A
    PLoS One; 2021; 16(7):e0254156. PubMed ID: 34310609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.